The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 03, 2015

Filed:

Apr. 11, 2008
Applicants:

Judith M. Gottwein, Frederiksberg, DK;

Troels Kasper Høyer Scheel, Copenhagen, DK;

Jesper Eugen-olsen, Hellerup, DK;

Jens Bukh, Præstø, DK;

Inventors:

Judith M. Gottwein, Frederiksberg, DK;

Troels Kasper Høyer Scheel, Copenhagen, DK;

Jesper Eugen-Olsen, Hellerup, DK;

Jens Bukh, Præstø, DK;

Assignee:

Hvidovre Hospital, Hvidovre, DK;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/29 (2006.01); A61K 39/12 (2006.01); C12N 7/02 (2006.01); C12N 15/06 (2006.01); C12Q 1/02 (2006.01); C07H 21/00 (2006.01); C12N 7/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C12N 7/00 (2013.01); A61K 2039/5254 (2013.01); C12N 2770/24251 (2013.01);
Abstract

A robust and genetically stable cell culture system for Hepatitis C Virus (HCV) genotype 3a is provided. A genotype 3a/2a (S52/JFH1) recombinant containing the structural genes (Core, E1, E2), p7 and NS2 of strain S52 was constructed and characterized in Huh7.5 cells. S52/JFH1 and J6/JFH viruses passaged in cell culture had comparable growth kinetics and yielded similar peak HCV RNA titers and infectivity titers. Direct genome sequencing of cell culture derived S52/JFH1 viruses identified putative adaptive mutations in Core, E2, p7, NS3, and NS5A; clonal analysis revealed that all genomes analyzed exhibited different combinations of these mutations. Finally, viruses resulting from transfection with RNA transcripts of five S52/JFH1 recombinants containing these combinations of putative adaptive mutations performed as efficiently as J6/JFH viruses in Huh7.5 cells and were all genetically stable after viral passage.


Find Patent Forward Citations

Loading…